home / stock / celz / celz news

CELZ News and Press, Creative Medical Technology Holdings Inc. From 05/08/25

Stock Information
Company Name: Creative Medical Technology Holdings Inc.
Stock Symbol: CELZ
Market: NASDAQ
Website: creativemedicaltechnology.com
Menu
CELZ CELZ Quote CELZ Short CELZ News CELZ Articles CELZ Message Board
Get CELZ Alerts

News, Short Squeeze, Breakout and More Instantly...
CELZ - CELZ - Historical Price Movements Surrounding Earnings

2025-05-08 18:48:19 ET Creative Medical Technology Holdings, Inc. (CELZ) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.85%. The average open to low on the day of earnings was -3.52%. ...
CELZ - CELZ - Historical Earnings Price Analysis

2025-05-08 18:43:19 ET Creative Medical Technology Holdings, Inc. (CELZ) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CELZ stock price following earnings has averaged ±1.43% , with ...

CELZ - Creative Medical Technology files to sell 1.8M shares of common stock by selling shareholders

2025-04-02 17:05:17 ET More on Creative Medical Technology Holdings, Inc. Seeking Alpha’s Quant Rating on Creative Medical Technology Holdings, Inc. Historical earnings data for Creative Medical Technology Holdings, Inc. Financial information for Creative Medi...

CELZ - Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain

PHOENIX, March 20, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (the “Company”), a clinical-stage biotechnology company specializing in regenerative medicine, today announced that the U.S. Food and Drug Administration (FDA) has cleared an ex...
CELZ - Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds

PHOENIX, March 06, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. , (Nasdaq: CELZ) (the “Company”), a leading biotechnology innovator in regenerative medicine, today announced it has entered into agreements with certain holders of its existing warrants for t...

CELZ - Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program's Success and Growth Potential

PHOENIX, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a leading biotechnology innovator in regenerative medicine, enthusiastically supports President Donald J. Trump’s executive order expanding access to in vitro fertilization (IVF). Thi...

CELZ - Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem(TM)

PHOENIX, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ) , a pioneering biotechnology firm specializing in regenerative medicine solutions for immunotherapy, endocrinology, urology, gynecology, and or...
CELZ - Creative Medical Technology Reports Positive One-Year Results for AlloStem(TM) Type 2 Diabetes Program

PHOENIX, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced promising one-year follow-up data from the AlloStem ™ (CELZ-201) Type 2 Diabetes pilo...

CELZ - Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development

PHOENIX, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical”) , a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced an expanded agreement with Greenstone Biosciences Inc. (&...

CELZ - Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain

PHOENIX, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) , a clinical-stage biotechnology company focused on regenerative medicine, today announced promising initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT,...
Previous 10 Next 10